UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6877) 6877
Book Chapter (138) 138
Newsletter (18) 18
Dissertation (15) 15
Book / eBook (6) 6
Newspaper Article (6) 6
Publication (4) 4
Government Document (2) 2
Conference Proceeding (1) 1
Magazine Article (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (5027) 5027
life sciences & biomedicine (4538) 4538
humans (4158) 4158
animals (3605) 3605
pharmacology & pharmacy (2603) 2603
male (2284) 2284
prodrugs - administration & dosage (2012) 2012
prodrugs (1737) 1737
prodrugs - pharmacokinetics (1722) 1722
female (1692) 1692
mice (1474) 1474
prodrugs - pharmacology (1436) 1436
prodrugs - chemistry (1263) 1263
rats (1213) 1213
prodrugs - therapeutic use (1197) 1197
chemistry (1053) 1053
physical sciences (1045) 1045
administration, oral (1041) 1041
prodrug (1040) 1040
drug delivery systems (862) 862
prodrugs - metabolism (846) 846
oncology (773) 773
adult (762) 762
cancer (746) 746
chemistry, multidisciplinary (730) 730
middle aged (693) 693
cell line, tumor (685) 685
drugs (656) 656
prodrugs - chemical synthesis (648) 648
biochemistry & molecular biology (560) 560
dose-response relationship, drug (534) 534
pharmacokinetics (523) 523
rats, sprague-dawley (511) 511
chemistry, medicinal (505) 505
aged (481) 481
biological availability (476) 476
antineoplastic agents - administration & dosage (450) 450
analysis (443) 443
prodrugs - adverse effects (436) 436
solubility (424) 424
hydrolysis (418) 418
neoplasms - drug therapy (400) 400
research (391) 391
tumors (384) 384
mice, nude (370) 370
treatment outcome (368) 368
care and treatment (366) 366
chemotherapy (360) 360
drug therapy (360) 360
antineoplastic agents - pharmacology (351) 351
enzymes (350) 350
pharmacology/toxicology (338) 338
health aspects (337) 337
drug delivery (333) 333
chromatography, high pressure liquid (329) 329
drug stability (328) 328
medicine, research & experimental (324) 324
research & experimental medicine (324) 324
molecular structure (320) 320
science & technology - other topics (316) 316
drug design (315) 315
antineoplastic agents - therapeutic use (306) 306
mice, inbred balb c (297) 297
chemical compounds (295) 295
half-life (290) 290
structure-activity relationship (290) 290
pharmacology (287) 287
antineoplastic agents - chemistry (285) 285
cell survival - drug effects (284) 284
tissue distribution (279) 279
injections, intravenous (274) 274
technology (270) 270
xenograft model antitumor assays (269) 269
rats, wistar (265) 265
vehicles (265) 265
nanoparticles (261) 261
hydrogen-ion concentration (260) 260
time factors (257) 257
disease models, animal (255) 255
biotransformation (247) 247
dogs (246) 246
area under curve (245) 245
drug delivery systems - methods (243) 243
deoxycytidine - analogs & derivatives (235) 235
in vitro techniques (234) 234
materials science (234) 234
dosage and administration (230) 230
tumor cells, cultured (230) 230
pharmacy (225) 225
toxicity (219) 219
biomedicine (218) 218
abridged index medicus (216) 216
genetic therapy - methods (215) 215
drug administration schedule (214) 214
kinetics (214) 214
biotechnology & applied microbiology (213) 213
antineoplastic agents - pharmacokinetics (212) 212
gene therapy (211) 211
double-blind method (204) 204
drug carriers (203) 203
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6928) 6928
Japanese (161) 161
German (70) 70
French (25) 25
Chinese (13) 13
Russian (13) 13
Spanish (8) 8
Portuguese (6) 6
Czech (3) 3
Italian (3) 3
Swedish (3) 3
Danish (2) 2
Dutch (2) 2
Arabic (1) 1
Norwegian (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


ACS nano, ISSN 1936-0851, 02/2017, Volume 11, Issue 2, pp. 2227 - 2238
Poor tumor penetration is a major challenge for the use of nanoparticles in anticancer therapy. Moreover, the inability to reach hypoxic tumor cells that are... 
hypoxia | cancer | nanoparticles | tumor penetration | iRGD | photodynamic therapy | Physical Sciences | Chemistry | Materials Science | Nanoscience & Nanotechnology | Technology | Materials Science, Multidisciplinary | Science & Technology - Other Topics | Chemistry, Multidisciplinary | Chemistry, Physical | Science & Technology | Prodrugs - administration & dosage | Hypoxia - drug therapy | Injections, Intravenous | Photosensitizing Agents - chemistry | Reactive Oxygen Species - metabolism | Nanoparticles - chemistry | Apoptosis - drug effects | Prodrugs - chemistry | Antineoplastic Agents - administration & dosage | Indocyanine Green - pharmacology | Photochemotherapy | Drug Delivery Systems | Tirapazamine - chemistry | Photosensitizing Agents - administration & dosage | Tissue Distribution | Indocyanine Green - chemistry | Photosensitizing Agents - pharmacology | Antineoplastic Agents - pharmacology | Molecular Structure | Tumor Cells, Cultured | Indocyanine Green - administration & dosage | Tirapazamine - administration & dosage | Tirapazamine - pharmacology | Antineoplastic Agents - chemistry | Reactive Oxygen Species - analysis | Animals | Cell Proliferation - drug effects | Mice | Nanoparticles - administration & dosage | Prodrugs - pharmacology | Drug Screening Assays, Antitumor | Index Medicus | Nanoparticles | Drugs | Therapy | Drug delivery systems | Photodynamic therapy | Penetration | Tumors | Anticancer properties | Hypoxia | Tumor Penetration | Photodynamic Therapy | Cancer
Journal Article
British journal of clinical pharmacology, ISSN 0306-5251, 10/2018, Volume 84, Issue 10, pp. 2422 - 2432
Journal Article
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 05/2008, Volume 26, Issue 13, pp. 2118 - 2123
We conducted a retrospective analysis of safety data from randomized, single-agent fluoropyrimidine clinical trials (bolus fluorouracil/leucovorin [FU/LV] and... 
Prodrugs - administration & dosage | Leucovorin - administration & dosage | Residence Characteristics | Capecitabine | United States | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Vitamin B Complex - administration & dosage | Antimetabolites, Antineoplastic - administration & dosage | Neoplasm Metastasis | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Fluorouracil - adverse effects | Colorectal Neoplasms - drug therapy | Deoxycytidine - adverse effects | Retrospective Studies | Chemotherapy, Adjuvant | Far East | Neutropenia - chemically induced | Gastrointestinal Diseases - ethnology | Severity of Illness Index | Colorectal Neoplasms - ethnology | Fluorouracil - analogs & derivatives | Risk Assessment | Deoxycytidine - administration & dosage | Europe | Treatment Outcome | Withholding Treatment | Neutropenia - ethnology | Prodrugs - adverse effects | Antimetabolites, Antineoplastic - adverse effects | Colorectal Neoplasms - pathology | Deoxycytidine - analogs & derivatives | Gastrointestinal Diseases - chemically induced | Index Medicus | pathology | Organoplatinum Compounds | Leucovorin | administration & dosage | Surgery | Colorectal Neoplasms | Adjuvant | ethnology | Fluorouracil | Neutropenia | drug therapy | chemically induced | Prodrugs | Antineoplastic | Antineoplastic Combined Chemotherapy Protocols | Antimetabolites | Kirurgi | Gastrointestinal Diseases | Chemotherapy | Deoxycytidine | analogs & derivatives | adverse effects | Vitamin B Complex
Journal Article
Journal Article
International journal of nanomedicine, ISSN 1176-9114, 01/2017, Volume 12, pp. 955 - 968
Background: Cervical cancer is a major world health problem for women. Currently, cancer research focuses on improving therapy for cervical cancer using... 
Combination therapy | Cervical cancer | Solid lipid nanoparticles | Cell-penetrating peptide | Lipid-based prodrug | Pharmacology & Pharmacy | Science & Technology - Other Topics | Nanoscience & Nanotechnology | Life Sciences & Biomedicine | Science & Technology | Prodrugs - administration & dosage | alpha-Tocopherol - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Nanoparticles - chemistry | Polyethylene Glycols | Antineoplastic Combined Chemotherapy Protocols - chemistry | Humans | Lipids | Uterine Cervical Neoplasms - drug therapy | Prodrugs - chemistry | Cisplatin - administration & dosage | Drug Carriers | Xenograft Model Antitumor Assays | Phosphatidylethanolamines | Animals | Cell Line, Tumor | Female | Mice | Mice, Inbred BALB C | Nanoparticles - administration & dosage | Paclitaxel - administration & dosage | Drug Delivery Systems - methods | Cell-Penetrating Peptides - chemistry | alpha-Tocopherol - chemistry | Paclitaxel | Development and progression | Dosage and administration | Models | Drug therapy | Cisplatin | Drug synergism | Drugs | Drug delivery systems | Peptides | Cytotoxicity | Cancer therapies | Nanoparticles | Biomedical materials | Womens health | Polyethylene glycol | Gene therapy | Deoxyribonucleic acid--DNA | Nanotechnology | Index Medicus | combination therapy | lipid-based prodrug | cell-penetrating peptide | solid lipid nanoparticles
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 11/2001, Volume 19, Issue 21, pp. 4097 - 4106
Journal Article